Emily Crossette
Appearances
- DateMay 8, 2023BACKGROUND: Recurrent _Clostridioides difficile _infection (rCDI) is a debilitating disease associated with significant healthcare burden and low quality of life. The greatest risk factor for rCDI is a history of recurrence, although older age (≥65 years) and comorbidities also increase risk…
- DateMay 18, 2024BACKGROUND: VE303 is a rationally defined consortium of 8 bacterial strains, designed to promote the establishment of a gut environment resistant to CDI…
- DateMay 18, 2024SOCIETY: AGA This session will feature cutting-edge research on the multifaceted aspects of Clostridioides difficile colitis, presenting the latest findings in pathogenesis and innovative therapeutic approaches. Attendees will gain valuable insights into the molecular and immunological aspects of C…
Moderators
Brigham and Women's HospitalBrigham and Women's Hospital